The HAS confirms the efficiency of Ziwig Endotest® for the diagnosis of endometriosis
9 January 2024
Ziwig, a French company at the forefront of biotechnology and women's health, announces that the French National Authority for Health (HAS) has confirmed the efficacy of the innovative salivary test for diagnosing endometriosis, Ziwig Endotest®. This test, which has already been awarded the Prix Galien and been the subject of publication in the New England Journal of Medicine Evidence, marks a major advance in the diagnosis of this complex condition
Ziwig launches GYN-ARN, a pioneering study to develop a salivary multi-pathology diagnostic test in gynaecology
18 December 2023
Ziwig, the cutting-edge French biotech specialized in the advanced analysis of salivary RNA, announces the launch of GYN-ARN, a highly promising new study in women's health.
Scientific validation of Ziwig Endotest® as a diagnostic tool for endometriosis by an article in the NEJM Evidence - New England Journal of Medicine.
12 June 2023
Ziwig, a French biotech and precursor in salivary RNA analysis, is proud to announce that Ziwig Endotest® has been validated as a diagnostic tool for endometriosis, according to a study published in the prestigious scientific journal NEJM Evidence - New England Journal of Medicine on 9th June, 2023.

Stay connected

Sign up to be notified of the latest news and publications.